Blue Earth Therapeutics

Blue Earth Therapeutics Ltd announces completion of $76.5M Series A financing to accelerate development of next generation targeted radioligand therapies
PR Newswire
Wed, 10/30/24 - 11:52 am
Blue Earth Therapeutics
funding
radioligands
Blue Earth Therapeutics partners with UCL for prostate cancer therapy trial
Clinical Trials Arena
Wed, 07/24/24 - 11:35 am
Blue Earth Therapeutics
radioligands
prostate cancer